 CAMBRIDGE, Mass., Dec. 22, 2020 PRNewswire -- Leap Therapeutics, Inc. Nasdaq:LPTX, a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the publication in Molecular Cancer Research of preclinical results from studies of human and... 